SOUTH BEND -- Marvin Miller, a chemistry professor at the University of Notre Dame, has received a $1.9 million grant from the National Institutes of Health for tuberculosis researchMiller and his research group aim to understand TB's essential iron sequestration machinery and develop novel anti-T

read more>>

Often causing no symptoms in carriers of the disease, worldwide tuberculosis (TB) infects eight to ten million people every year, kills two million, and it is highly contagious as it is spread through coughing and sneezing"It's a global health disaster waiting to happen, even here in Canada, but t

read more>>

OTTAWA -- DNA Genotek, a leading provider of products for biological sample collection, stabilization and preparation, today announced that the world's leading TB vaccine research site, the South African Tuberculosis Vaccine Initiative (SATVI), has chosen Oragene-DNA for a study aimed at This stud

read more>>

Frederick, MD -- Akonni Biosystems®, a molecular diagnostics (MDx) company focused on developing and manufacturing rapid, high multiplex solutions for infectious disease testing, today announced receipt of a $435K grant from the National Institutes of Biomedical Imaging and Bioengineering at T

read more>>

An international team of researchers comparing recently-developed methods for diagnosing tuberculosis in children in resource-poor countries has concluded that the best test for high-risk children is the microscopic-observation drug-susceptibility (MODS) techniqueMODS detects the presence of bacte

read more>>

ROCKVILLE, Md. -- Sequella, Inc., a clinical-stage biopharmaceutical company developing drugs for treatment of life-threatening infectious diseases, announced today the publication of studies in the scientific journal Antimicrobial Agents and Chemotherapy on synergy between SQ109, its lead drug Re

read more>>

BRONX, NY -- For the third time in four months, the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University a research grant aimed at helping people infected with multidrug-Taken

read more>>

A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard

read more>>

ROCKVILLE, MD and SEOUL, KOREA -- The emergence and spread of drug-resistant mycobacterium tuberculosis (TB) threatens global TB control efforts, and there is an urgent need for new diagnostic tests that rapidly identify drug sensitivity profiles of TB strainsTo help address these concerns, Seegen

read more>>

Compounds being developed against tuberculosis also show promise against deadly tropical diseases threatening millions of people, two not-for-profits groups said on Wednesday, announcing a deal to speed up drug developmentThe Global Alliance for TB Drug Development has granted the Drugs for Neglec

read more>>